|
Re: Zometa in adjuvant for younger women
Looking at the various info above, seems to me the balance tips towards benefit. Downside probably eth usual additional kidney stress and the controversial osteonecrosis of jaw and fracture risk. All relative of course.
Regarding insurance, I think it's good practice to see how much a non-covered treatment actually costs before taking it off the table.
|